| SECTOR | INDUSTRY |
| Health Care | Life Sciences Tools & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Rosalio Madrigal
Tudor Pop
Jenna Brashear
| Share Statistics | A | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $44,144.1 | $3,076.5 | 92% |
|
| Shares Out (Mil) | 283.0 | 96.5 | 82% |
|
| Institutional Ownership | 99.7% | 90.0% | 92% |
|
| Float (Mil) | 281.5 | 71.5 | 79% |
|
| Beta | 1.23 | 1.22 | 73% |
|
| Avg Daily Volume (000s) | 1,644 | 710 | 78% |
|
| Price Change (52-week) |
30.1% | 89.4% | 69% |
|
| Growth | A | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 5.4% | 7.8% | 38% |
|
| Net Income (5yr) | 12.6% | (13.7%) | 59% |
|
| EPS (5yr) | 14.7% | 0.7% | 55 |
|
| Dividends (5yr) | 6.6% | 0.0% | 79% |
|
| Cash Flow (5yr) | 53.5% | (15.0%) | 94% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 17 | 21 | 21 | |
| Current EPS | $1.486 | $6.059 | $6.608 | |
| Month Ago EPS | $1.486 | $6.058 | $6.612 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $1.497 | $5.972 | $6.572 | |
| Year/Year Chg | 23.8% | 32.6% | 60.8% | |
| Financials | A | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $7,232 | $800 | 80% |
|
| Net Income (TTM) (Mil) | $1,414 | ($31) | 89% |
|
| EPS (TTM) | $4.996 | ($0.300) | 86% |
|
| Operating Cash Flow (TTM) (Mil) | $1,452 | $47 | 85% |
|
| Net Cash Flow (TTM) (Mil) | $320 | $5 | 88% |
|
| Long-Term Debt (Q1) (Mil) | $3,238 | $270 | 80% |
|
| Enterprise Value (Q1) (Mil) | $43,603 | $3,795 | 91% |
|
| Valuation | A | Industry Median |
Percentile (All Stocks) |
|
| P/B | 6.19 | 3.68 | 82% |
|
| P/E | 31.4 | 39.8 | 71% |
|
| Dividend Yield | 0.7% | 0.0% | 64% |
|
| PEG (5yr hist) | 2.1 | 5.5 | 70% |
|
| Ratios | A | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 52.6% | 47.7% | 65% |
|
| Net Margin | 19.6% | (3.2%) | 78% |
|
| ROA | 11.2% | (4.3%) | 89% |
|
| ROE | 21.3% | (7.9%) | 81% |
|
| Liabilities to Assets | 45.5% | 42.0% | 37% |
|
| F-Score | 7 | 5 | 82% |
|
Passing Stock Screens
As of 8/20/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 13.2% |
| +/- S&P 500: | +5.7 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
